thiazoles has been researched along with Gram-Positive Bacterial Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Z; Deng, Q; Qu, D; Tang, Y; Wu, Y; Xiong, Y; Yu, Z; Zhao, Y; Zheng, J | 1 |
| Budriesi, R; Caputo, L; Cavalluzzi, MM; Corazza, I; De Salvia, MA; Franchini, C; Gualdani, R; Lentini, G; Micucci, M; Milani, G; Piarulli, M; Quintieri, L; Rosato, A; Viale, M | 1 |
| Kawai, H; Shiojiri, T | 1 |
| Assar, NH; Bondock, S; Ibrahim, YM; Nasr, T | 1 |
| Delk, KW; Divers, S; Jiménez, DA; Kent, M; Mayer, J; Mejia-Fava, J; Myrna, K | 1 |
| Chen, L; Cooper, B; Cushman, M; Mayhoub, A; Mohammad, H; Oldfield, E; Peters, CE; Pogliano, J; Pogliano, K; Seleem, MN; Younis, W; Zhang, J | 1 |
| Hu, Z; Ma, X; Xiang, G; Zhang, S; Zhou, W | 1 |
| Amaral, K; Brewer, JT; Bushell, SM; Dewhurst, JM; Dzink-Fox, J; Gangl, E; Goldovitz, J; Jain, A; LaMarche, MJ; Leeds, JA; Mullin, S; Neckermann, G; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Sachdeva, M; Shao, J; Tiamfook, S; Whitehead, L; Yu, D | 1 |
| Dzink-Fox, J; Gangl, E; Krastel, P; LaMarche, MJ; Leeds, JA; Neckermann, G; Palestrant, D; Patane, MA; Rann, EM; Tiamfook, S; Yu, D | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Berti, M; Denaro, M; Goldstein, BP; Resconi, A; Ripamonti, F; Scotti, R | 1 |
11 other study(ies) available for thiazoles and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Daptomycin; Drug Synergism; Enterococcus faecium; Gram-Positive Bacterial Infections; Histidine Kinase; Humans; Microbial Sensitivity Tests; Recombinant Proteins; Thiazoles | 2022 |
Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.
Topics: Animals; Anti-Bacterial Agents; Antidiarrheals; Bacteria; Colon; Diarrhea; Dose-Response Relationship, Drug; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Guinea Pigs; Ileum; Loperamide; Male; Microbial Sensitivity Tests; Muscle Contraction; Neuroprotective Agents; Piperidines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Thiazoles | 2021 |
Internal jugular vein thrombosis associated with
Topics: Abscess; Anti-Bacterial Agents; Blood Culture; Buttocks; Carnobacteriaceae; Drainage; Duration of Therapy; Factor Xa Inhibitors; Gram-Positive Bacterial Infections; Humans; Jugular Veins; Male; Middle Aged; Pulmonary Embolism; Pyridines; Thiazoles; Thrombophlebitis; Tomography, X-Ray Computed | 2021 |
Bactericidal activity of a substituted thiazole against multidrug-resistant Eggerthia catenaformis isolated from patients with dental abscess.
Topics: Abscess; Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Resistance, Multiple, Bacterial; Egypt; Firmicutes; Gram-Positive Bacterial Infections; Humans; Stomatognathic Diseases; Thiazoles | 2021 |
Diagnostic imaging of peripheral vestibular disease in a Chinese goose (Anser cygnoides).
Topics: 4-Butyrolactone; Animals; Anseriformes; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bird Diseases; Clindamycin; Evoked Potentials, Auditory, Brain Stem; Gram-Positive Bacterial Infections; Male; Meloxicam; Radiography; Sulfones; Thiazines; Thiazoles; Vestibular Diseases | 2014 |
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.
Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Cell Wall; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Models, Molecular; Thiazoles; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Benzamides; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Mycobacterium smegmatis; Pyridines; Staphylococcus aureus; Thiazoles | 2017 |
Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: identification of the cycloalkylcarboxylic acids.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carboxylic Acids; Crystallography, X-Ray; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mutation; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Sepsis; Solubility; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2011 |
Antibiotic optimization and chemical structure stabilization of thiomuracin A.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Crystallography, X-Ray; Enterococcus; Escherichia coli; Escherichia coli Proteins; Female; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptide Elongation Factor Tu; Peptides, Cyclic; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Streptococcus pyogenes; Structure-Activity Relationship; Thiazoles; Transcription, Genetic | 2012 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A).
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Staphylococcus; Streptococcus; Thiazoles | 1993 |